Cardiovascular

Rapid Genotype Assay for Individualized Warfarin Dosing

Jeffrey Anderson
Jeffrey Anderson

Douglas Zipes
Douglas Zipes

JEFFREY ANDERSON, University of Utah, Salt Lake City
COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis

REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans
The hope of refining treatments for cardiovascular disease by genotyping patients to detect individual sensitivities to particular medical therapies was brought a step closer at the ACC meeting in New Orleans by results from a study using a rapid genothype test. Jeffrey Anderson told Peter Goodwin about the assay they’ve been investigating which indicates required dosing of warfarin.

Similar Interviews

  • Once-And-For-All TB Assay Brings Cheap, Sensitive, Specific, Seven-Day Diagnosis and Drug-Susceptibility Testing
  • DAVID MOORE, Imperial College, London and Lima REFERENCE: N Engl J Med 355: 1539-50 A new test for TB, trialled in Peru,

  • Warfarin Trumps Platelet Agents in Atrial Fibrilation
  • For atrial fibrillation, oral anti-coagulation remains the treatment of choice despite the potential of an anti-platelet regimen based on aspirin

  • Cardiovascular Medicine
  • Cardiologists and doctors whose patients have cardiovascular disease in any form receive up-to-date audio information via the audio journal of
    1. [...] Jeffrey Anderson. Douglas Zipes. JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis. REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans … …more [...]

      Posted by cardiovascular-medicine » Blog Archive » Audio Journal of Cardiovascular Medicine: Rapid Genotype Assay for … | July 8, 2007, 9:40 am

    Post a comment

    Subscribe to Audio Medica Podcast